Fusidic acid
- Generic Name
- Fusidic acid
- Brand Names
- Fucibet, Fucidin, Fucithalmic
- Drug Type
- Small Molecule
- Chemical Formula
- C31H48O6
- CAS Number
- 6990-06-3
- Unique Ingredient Identifier
- 59XE10C19C
- Background
An antibiotic isolated from the fermentation broth of Fusidium coccineum. (From Merck Index, 11th ed) It acts by inhibiting translocation during protein synthesis. It is often used topically in creams and eyedrops but is available in systemic formulations including tablets and injections.
- Indication
For the treatment of bacterial infections.
- Associated Conditions
- Bacterial Conjunctivitis, Eye and eyelid infections, Fungal skin infection, Skin Infections caused by Corynebacterium minutissimum infection, Skin Infections caused by Staphylococcus Aureus, Skin Infections caused by Streptococcus Infection, Stye, Bacterial skin infections, Cutaneous dermatophyte infection, Eczematous rash, Mild Atopic dermatitis, Mild Dermatitis caused by Staphylococcus aureusis, Moderate Atopic dermatitis, Moderate Dermatitis caused by Staphylococcus aureusis, Ocular bacterial infections, Susceptible Bacterial Infections
- Associated Therapies
- -
Antimicrobial Adjuvants to Revert the Imbalance of Skin Microbiota for Improved Outcomes of Complicated Cutaneous Leishmaniasis Treatment in Ethiopia
- Conditions
- Interventions
- First Posted Date
- 2024-11-19
- Last Posted Date
- 2024-11-19
- Lead Sponsor
- Institute of Tropical Medicine, Belgium
- Target Recruit Count
- 180
- Registration Number
- NCT06695143
- Locations
- 🇪🇹
Arba Minch General Hospital, Arba Minch, Ethiopia
🇪🇹Chencha Primary Hospital, Chencha, Ethiopia
Study to Determine the Efficacy&Safety of ARV-1801(ACG-701) for the Treatment of Cystic Fibrosis Pulmonary Exacerbations
- Conditions
- Interventions
- First Posted Date
- 2022-12-07
- Last Posted Date
- 2023-07-19
- Lead Sponsor
- Aceragen
- Registration Number
- NCT05641298
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
🇺🇸New York Medical College, Hawthorne, New York, United States
🇺🇸Vanderbilt University Medical Center, Nashville, Tennessee, United States
S. Aureus Decolonization in HPN Patients.
- First Posted Date
- 2017-06-01
- Last Posted Date
- 2022-05-31
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 63
- Registration Number
- NCT03173053
- Locations
- 🇩🇰
Rigshospitalet, Copenhagen, Denmark
🇩🇰Aalborg Universitetshospital, Aalborg, Denmark
🇳🇱Radboud UMC, Nijmegen, Gelderland, Netherlands
Oral Sodium Fusidate (CEM-102) Versus Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections
- Conditions
- Interventions
- First Posted Date
- 2015-10-07
- Last Posted Date
- 2019-04-19
- Lead Sponsor
- Arrevus Inc.
- Target Recruit Count
- 716
- Registration Number
- NCT02570490
Oral Sodium Fusidate (CEM-102) for the Treatment of Staphylococcal Bone or Joint Infections
- First Posted Date
- 2015-10-06
- Last Posted Date
- 2020-01-30
- Lead Sponsor
- Arrevus Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT02569541
Scars After Central Venous Catheters
- Conditions
- Interventions
- First Posted Date
- 2010-04-29
- Last Posted Date
- 2014-02-12
- Lead Sponsor
- Mette Møller Handrup
- Target Recruit Count
- 60
- Registration Number
- NCT01113125
- Locations
- 🇩🇰
Arhus University Hospital Skejby, Aarhus, Aarhus N, Denmark
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.